Agree oversold. I have EPS at around $9.15 for FY17 (still being conservative). At current SP, PE is around 17. Unbelievable value. I would ignore the IF sales and focus on their vitamins business. BKL will persevere for at least one year and then decide on their IF sales IMO.
Add to My Watchlist
What is My Watchlist?